Last updated on August 2015

A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of AMG 344 in Migraine Prevention


Brief description of study

A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of AMG 344 in Migraine Prevention

Detailed Study Description

This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of migraine headaches. If you qualify for participation in this study, your participation would last approximately 60 weeks and you would be required to make about 18 office visits to our clinic at 2525 W. Greenway Road, Phoenix 85023. As a qualified participant you will be compensated $50 per visit. Also, as a participant in the study you will receive study medication or placebo, physical exams, lab tests and other medical tests as necessary for the completion of the study, at no cost to you.

Clinical Study Identifier: TX141205

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )